Objective: The purpose of this study was to evaluate the extent and mechanism anti-cancer drug-loaded liposomes using wheat germ agglutinin as a guiding molecule. Methods: For the drug-loaded liposome synthesis, the thin film hydration method was used and the drug cisplatin was loaded during the synthesis and followed by the surface modification using wheat germ agglutinin (WGA) lectin. The developed system was confirmed based on transmission electron microscopy (TEM), atomic force microscopy (AFM), particle size (PS) analyzer, polydispersity index and Zeta Potential analyzer. Results: The results showed the surface modified by liposomes had the particle size 200±5 nm. The wheat germ agglutinin coated on the surface to liposome led to a red...
Lung cancer is one of the most common cancers with small cell lung cancer (SCLC) representing 18% of...
Cytotoxic anticancer drugs lack specificity and for this reason, antitumour effects are often assoc...
Purpose: To evaluate the cytotoxicity of pegylated nanoliposomal cisplatin on human ovarian cancer c...
Objective: The purpose of this study was to evaluate the extent and mechanism anti-cancer drug-loade...
Cisplatin is one of the conventional drugs used in chemotherapy which has a potent antitumor functio...
Purpose: This study was aimed at exploring the use of liposomes to deliver aquated cisplatin (ACP), ...
Cisplatin, is an anticancer drug, belongs to alkylating agent_s class. Cisplatin is commonly used fo...
Gynecological tumors are major therapeutic areas of platinum-based anticancer drugs. Here, we report...
Cisplatin (CDDP) is a platinum-based antineoplastic drug that is approved by the U.S. Food and Drug ...
Cisplatin was encapsulated into multivesicular liposomes (MVLs) and the entrapment efficiency, size ...
Jingde Chen,* Hong Jiang,* Yin Wu, Yandong Li, Yong GaoDepartment of Oncology and Hematology, East H...
This study aims to evaluate the potency of cisplatin (Cispt)-loaded liposome (LCispt) and PEGylated ...
BACKGROUND: Liposomes, used to improve the therapeutic index of new and established drugs, have a...
Platinum-based chemotherapy, such as cisplatin, oxaliplatin, and carboplatin, is one of the most wid...
The current study aimed to develop pH-responsive cisplatin-loaded liposomes (CDDP@PLs) via the thin ...
Lung cancer is one of the most common cancers with small cell lung cancer (SCLC) representing 18% of...
Cytotoxic anticancer drugs lack specificity and for this reason, antitumour effects are often assoc...
Purpose: To evaluate the cytotoxicity of pegylated nanoliposomal cisplatin on human ovarian cancer c...
Objective: The purpose of this study was to evaluate the extent and mechanism anti-cancer drug-loade...
Cisplatin is one of the conventional drugs used in chemotherapy which has a potent antitumor functio...
Purpose: This study was aimed at exploring the use of liposomes to deliver aquated cisplatin (ACP), ...
Cisplatin, is an anticancer drug, belongs to alkylating agent_s class. Cisplatin is commonly used fo...
Gynecological tumors are major therapeutic areas of platinum-based anticancer drugs. Here, we report...
Cisplatin (CDDP) is a platinum-based antineoplastic drug that is approved by the U.S. Food and Drug ...
Cisplatin was encapsulated into multivesicular liposomes (MVLs) and the entrapment efficiency, size ...
Jingde Chen,* Hong Jiang,* Yin Wu, Yandong Li, Yong GaoDepartment of Oncology and Hematology, East H...
This study aims to evaluate the potency of cisplatin (Cispt)-loaded liposome (LCispt) and PEGylated ...
BACKGROUND: Liposomes, used to improve the therapeutic index of new and established drugs, have a...
Platinum-based chemotherapy, such as cisplatin, oxaliplatin, and carboplatin, is one of the most wid...
The current study aimed to develop pH-responsive cisplatin-loaded liposomes (CDDP@PLs) via the thin ...
Lung cancer is one of the most common cancers with small cell lung cancer (SCLC) representing 18% of...
Cytotoxic anticancer drugs lack specificity and for this reason, antitumour effects are often assoc...
Purpose: To evaluate the cytotoxicity of pegylated nanoliposomal cisplatin on human ovarian cancer c...